EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Cathepsin B-inhibitor promotes the development of Th1 type protective T cells in mice infected with Leishmania major



Cathepsin B-inhibitor promotes the development of Th1 type protective T cells in mice infected with Leishmania major



Journal of Medical Investigation 44(1-2): 33-39



BALB/c mice are genetically susceptible to infection with Leishmania major (L. major). When such mice infected with L. major were treated with specific inhibitors of cathepsin B, a lysosomal cysteine protease that digests exogenous antigenic proteins, the mice acquired resistance against L. major infection. T cells from these mice produced large amounts of IFN-gamma and low amounts of IL-4 as compared with those of untreated BALB/c mice. In addition, the mice treated with cathepsin B inhibitor produced a high titer of IgG2a specific antibodies and only low titers of IgG1 and IgE antibodies. This type of response is in contrast with the high specific IgG, or IgE antibody responses which are the usual antibody responses in BALB/c mice infected with L. major. These findings indicate that cathepsin B may be critically involved in processing antigens of L. major to promote exclusively the development of Th2 type CD 4+ T cell responses.

(PDF emailed within 1 workday: $29.90)

Accession: 003060685

Download citation: RISBibTeXText

PMID: 9395715



Related references

Treatment with cathepsin L inhibitor potentiates Th2-type immune response in Leishmania major-infected BALB/c mice. International Immunology 13(8): 975-982, 2001

Flt3 ligand induces skin dendritic cells and is protective against disease progression in susceptible BALB/C mice infected with Leishmania major. Journal of Investigative Dermatology 112(4): 524, April, 1999

iNOS-producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection phase of C57BL/6 resistant mice. Plos Pathogens 5(6): E1000494-E1000494, 2009

Expansion of gamma delta+ T cells in BALB/c mice infected with Leishmania major is dependent upon Th2-type CD4+ T cells. Infection and Immunity 63(8): 3000-3004, 1995

Protective Th1 response promotes resistance to Leishmania major infection in TGF-beta1 deficient mice. Journal of Interferon & Cytokine Research 22(Supplement 1): S-163, 2002

The influence of the site of parasite inoculation on the development of Th1 and Th2 type immune responses in (BALB/c x C57BL/6) F1 mice infected with Leishmania major. Parasite Immunology 17(11): 569-579, 1995

Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production. Journal of Immunology 184(2): 886-894, 2010

Protective role of the pefloxacin-IFN-gamma association in Leishmania major-infected mice. New Microbiologica 19(1): 39-46, 1996

The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb. European Journal of Immunology 28(2): 525-531, 1998

Protective effect of isoprinosine in genetically susceptible BALB/c mice infected with Leishmania major. Immunology 74(1): 25-30, 1991

Leishmania major infection in major histocompatibility complex class II-deficient mice: CD8+ T cells do not mediate a protective immune response. Immunobiology 195(2): 243-260, 1996

Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major. Journal of Experimental Medicine 186(7): 1137-1147, 1997

Antileishmanial activity of licochalcone A in mice infected with Leishmania major and in hamsters infected with Leishmania donovani. Antimicrobial Agents and ChemoTherapy 38(6): 1339-1344, 1994

Amastigote load and cell surface phenotype of infected cells from lesions and lymph nodes of susceptible and resistant mice infected with Leishmania major. Infection and Immunity 71(5): 2704-2715, 2003